Virtu Financial’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,426
Closed -$39K 1699
2025
Q4
$39K Buy
+3,426
New +$52.9K ﹤0.01% 1333
2025
Q1
Sell
-1,673
Closed -$62K 1424
2024
Q4
$62K Buy
+1,673
New +$64K ﹤0.01% 1117
2024
Q1
Sell
-2,376
Closed -$219K 1470
2023
Q4
$219K Buy
+2,376
New +$242K 0.02% 763
2021
Q4
Sell
-728
Closed -$611K 1750
2021
Q3
$611K Buy
+728
New +$739K 0.05% 375
2021
Q1
Sell
-309
Closed -$442K 1635
2020
Q4
$442K Buy
+309
New +$330K 0.05% 476
2020
Q3
Sell
-465
Closed -$325K 1109
2020
Q2
$325K Buy
+465
New +$269K 0.04% 516
2018
Q2
Sell
-1,466
Closed -$215K 2006
2018
Q1
$215K Buy
+1,466
New +$248K 0.01% 1305

Other funds holding CDLX

Virtu Financial's CDLX Position: Q1 2026 in Review

Virtu Financial sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 3,426 shares — an estimated $39K sold.

Virtu Financial first reported a position in CDLX in Q1 2018 and held it in 7 quarters. The position peaked at $611K in Q3 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Virtu Financial reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 3,426 Cardlytics shares in Q1 2026, an estimated $39K.
  • Virtu Financial first reported a position in Cardlytics in Q1 2018 and held it in 7 quarters.
  • Virtu Financial's Cardlytics position peaked at $611K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.